Variant report
Variant | nsv562563 |
---|---|
Chromosome Location | chr13:85528032-85551906 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs386772908 | chr13:85534237-85534238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs9602612 | chr13:85534254-85534255 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs551805451 | chr13:85534264-85534265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs77535445 | chr13:85534289-85534290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140186393 | chr13:85534302-85534303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs143867146 | chr13:85534318-85534319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs146854943 | chr13:85534417-85534418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs9593962 | chr13:85534434-85534435 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs546980310 | chr13:85534473-85534474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs9602613 | chr13:85534477-85534478 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs148989136 | chr13:85534478-85534479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs4460967 | chr13:85534486-85534487 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs573496259 | chr13:85534488-85534489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs537230950 | chr13:85534507-85534508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs9593963 | chr13:85534519-85534520 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs142916412 | chr13:85534555-85534556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544855414 | chr13:85534564-85534565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs4460968 | chr13:85534612-85534613 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs191629219 | chr13:85534633-85534634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs151074553 | chr13:85534651-85534652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563789707 | chr13:85534704-85534705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs530935236 | chr13:85534713-85534714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs575440211 | chr13:85534724-85534725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs10538761 | chr13:85534763-85534764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs398099044 | chr13:85534766-85534767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs60213325 | chr13:85534776-85534777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs565901329 | chr13:85534794-85534795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs139402911 | chr13:85534796-85534797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs375030603 | chr13:85534798-85534799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs557143500 | chr13:85534813-85534814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs368517801 | chr13:85534834-85534835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs372245163 | chr13:85534838-85534839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374852865 | chr13:85534842-85534843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs543202931 | chr13:85534845-85534846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs559797256 | chr13:85534846-85534847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs71695966 | chr13:85534847-85534848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs34293760 | chr13:85534861-85534862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560870849 | chr13:85534902-85534903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs140987461 | chr13:85534965-85534966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs146361347 | chr13:85534971-85534972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs146396131 | chr13:85534975-85534976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs138988658 | chr13:85535001-85535002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs370532320 | chr13:85535015-85535016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs57859460 | chr13:85535024-85535025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs532904848 | chr13:85535026-85535027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs551122622 | chr13:85535029-85535030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs569730809 | chr13:85535032-85535033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs141452168 | chr13:85535038-85535039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs555514491 | chr13:85535040-85535041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs567424693 | chr13:85535045-85535046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21858162 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 19490664 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:85534200-85536200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr13:85536200-85536600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr13:85536400-85536800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr13:85536600-85537000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr13:85547000-85547200 | Enhancers | Gastric | stomach |
6 | chr13:85547800-85548400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr13:85547800-85548400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
8 | chr13:85547800-85548600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr13:85547800-85548600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr13:85547800-85548600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
11 | chr13:85547800-85549400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr13:85548000-85548400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr13:85548000-85548400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
14 | chr13:85548000-85548400 | Enhancers | Fetal Kidney | kidney |
15 | chr13:85548000-85548600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr13:85548000-85548600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
17 | chr13:85548200-85548600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
18 | chr13:85548400-85552400 | Weak transcription | Fetal Kidney | kidney |
19 | chr13:85548600-85549000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
20 | chr13:85548600-85550000 | Enhancers | Primary B cells from cord blood | blood |
21 | chr13:85549000-85549200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
22 | chr13:85549200-85552600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
23 | chr13:85549400-85552600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |